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1. Introduction 
Autoimmune pancreatitis (AIP) is a rare disorder of presumed autoimmune etiology with 
specific pathologic features, and is an increasingly recognized clinical condition. AIP is 
characterized histologically by fibrosis with dense infiltration of T lymphocytes and IgG4-
positive plasma cells in the peripancreatic and interlobular area of the pancreas (1-4). 
Patients with AIP usually have serum markers of autoimmune disorders, such as increased 
IgG4 and antinuclear antibodies. Although clinical features and symptoms are nonspecific, 
association with many other autoimmune disorders have also been reported (5-10). 
Therefore AIP should be considered in differential diagnosis when a patient with another 
autoimmune condition presents with symptoms related to the pancreas and biliary tract.  
AIP has been described in literature to respond well to steroid therapy. Also, imaging 
appearances of AIP improve with steroid therapy, so imaging can be used in evaluation of 
treatment (11-16). Correct diagnosis is essential for appropriate treatment planning and to 
avoid unnecessary surgery. In particular, differentiation of AIP from pancreatic 
malignancies is very important, and several characteristic imaging features have been 
reported (16-18). 
This article presents imaging appearances of AIP described in several radiological publications.  
2. Imaging findings of AIP 
AIP is mainly indicated by an imaging procedure such as contrast enhanced computed 
tomography (CT) or magnetic resonance imaging (MRI) (16, 18-22). 
The classic finding of contrast enhanced CT that is diagnostic or highly suggestive of AIP is 
the diffuse sausage shaped enlargement of the entire pancreas with homogeneous 
attenuation, moderate enhancement and featureless, pencil sharp borders, absent of the 
normal pancreatic clefts (Figure1-4). The pancreas is covered with a thin capsular-like low 
density rim that possibly represents inflammatory exudates (Fig 1ab). Usually there is no 
calcification, peripancreatic fluid collection or vascular involvement. Though the diffuse 
form is most commonly reported in literature, focal forms have been reported, and the 
involved segment may mimic a pancreatic tumor, consequently most patients with focal 
forms of AIP underwent surgery, because of preoperative diagnoses of pancreatic carcinoma 
(Figure 4)(16-18, 23, 24).  
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A, Contrast enhanced axial CT scan shows diffuse enlargement of the pancreas with sharp borders and 
minimal peripancreatic stranding (arrow), B, MRI shows diffuse pancreatic enlargement with minimal 
high signal intensity on T2-weighted MR images. 
Fig. 1. (A,B) Images obtained in 58-year-old man with diffuse form of AIP who had jaundice 
and abdominal pain at presentation.  
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Endoscopic retrograde cholangiopancreatographic (ERCP) image shows diffuse narrowing of 
pancreatic duct with irregular walls (C; arrrows), and focal stricture in distal common bile duct (D; 
arrrow). 
Fig. 1. (C,D) Images obtained in 58-year-old man with diffuse form of AIP who had jaundice 
and abdominal pain at presentation.  
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E, Axial CT scan shows that enlargement of the pancreas diminished after steroid therapy. 
Fig. 1. (E) Images obtained in 58-year-old man with diffuse form of AIP who had jaundice 
and abdominal pain at presentation.  
A diffusely enlarged pancreas can be also seen in diffuse infiltrative pancreatic carcinoma, 
malignant lymphoma, plasmacytoma, or metastases. However, in most of these conditions, 
imaging features are usually different from those observed in AIP. 
Compared with normal pancreatic parenchyma, diffuse or localized enlargement of the 
pancreas is seen as low intensity on T1-weighted MR images and high intensity on T2-
weighted images (Figure1b). Diffusion-weighted MR images (DWI) are considered useful for 
detecting AIP and for evaluating the effect of steroid therapy. AIP is seen as high signal 
intensity on DWI (Figure4c), which improved after steroid treatment. Apparent diffusion 
coefficients (ADCs) also reflected disease activity (Fiure4d). Thus, DWI is considered a 
valuable tool for detecting AIP, determining the affected area, and evaluating the effect of 
treatment (25, 26). In many cases, ADC values are lower in AIP than in pancreatic cancer, so an 
ADC cut off value is potentially useful for distinguishing AIP from pancreatic cancer (26).  
Magnetic resonance cholangiopancreatography (MRCP) is a non-invasive method to 
evaluate the pancreatic duct and biliary tract, and recently, the imaging quality has 
increased to almost the equivalent of endoscopic retrograde cholangiopancreatography 
(ERCP). ERCP is thought to be the most accurate diagnostic modality for AIP, especially 
when evaluating the pancreatic duct (27). Both MRCP and ERCP show characteristic diffuse 
narrowing with irregularities or serration along various segments of the main pancreatic 
duct (Figure1c, 3d). Sometimes, there may be a focal stricture. The intrapancreatic segment 
of the common bile duct may be focally or segmentally narrowed resulting in dilatation of 
the proximal bile duct (Figure1d, 3d). 
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Axial CT scan obtained at the level of the proximal portion of superior mesenteric artery shows 
circumferential thickening of periarterial soft tissue (arrow) consistent with sclerosing messenteritis. 
Fig. 2. 52-year-old man with diffuse form of AIP.  
 
A 
A, Contrast enhanced axial CT scan shows diffuse enlargement of the pancreas with sharp borders and 
minimal peripancreatic stranding (arrow). 
Fig. 3. (A) 54-year-old man with diffuse form of AIP. 
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B, Swelling of the pancreatic head is also seen (arrow)., C, Transabdominal transverse US image shows 
enlargement of the pancreatic head with minimal decreased echotexture of pancreas (arrows). 
Fig. 3. (B,C) 54-year-old man with diffuse form of AIP. 
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D, MRCP image also shows the narrowing of the main pancreatic duct with irregular walls and focal 
stricture in the distal common bile duct (arrrow),.E, Axial CT scan obtained after steroid therapy shows 
a normal-appearing pancreas, and enlargement of the pancreas is diminished.  
Fig. 3. (D,E) 54-year-old man with diffuse form of AIP. 
www.intechopen.com
 Pancreatitis – Treatment and Complications 
 
126 
 
A 
 
B 
Contrast enhanced CT scan shows focal enlargement in the pancreatic body and tail with sharp borders 
and a thin capsular-like rim. The lesion appears as a relatively low attenuation area compared to normal 
pancreatic parenchyma on early phase (A), and as an almost iso-attenuation area compared to normal 
pancreatic parenchyma on delayed phase (B) (arrows). Hydronephrosis on the left is also seen due to 
concurrent retroperitoneal fibrosis. 
Fig. 4. (A,B) 62-year-old man with focal form of AIP. 
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C, Diffusion-weighted MR image shows a focal high-intensity area on the pancreatic body and tail 
(arrow) (b=800mm2/s). D, ADC map shows low ADC value  (1.014×10-3mm2/sec) on the pancreatic body 
and tail (arrow) . 
Fig. 4. (C,D) 62-year-old man with focal form of AIP. 
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E 
E, Combined PET/CT scan shows strong FDG uptake at the pancreatic body and tail (arrow). 
Fig. 4. (E) 62-year-old man with focal form of AIP. 
FDG-PET/CT is useful for detecting AIP and associated extrapancreatic autoimmune 
lesions and for monitoring their disease activity. AIP can cause intense FDG uptake in the 
pancreas (Figure4e). AIP should always be considered when making a diagnosis with FDG-
PET in patients with pancreatic disorders. In many cases, differentiation of AIP from 
pancreatic malignancies is thought to be difficult by PET/CT (28-30). Lee et al reported that 
in difficult cases, on PET/CT imaging, the presence of diffuse uptake of FDG by the 
pancreas or concomitant extrapancreatic uptake by the salivary glands may aid in 
differentiation of autoimmune pancreatitis and pancreatic cancer (29). 
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Pancreatitis may be acute or chronic. Although they can be caused by similar aetiologies, they tend to follow
distinct natural histories. Around 80% of acute pancreatitis (AP) diagnoses occur as secondary to gallstone
disease and alcohol misuse. This disease is commonly associated with the sudden onset of upper abdominal
that is usually severe enough to warrant the patient seeking urgent medical attention. Overall, 10 to 25% of AP
episodes are classified as severe, leading to an associated mortality rate of 7 to 30%. Treatment is
conservative and consists of general medical support performed by experienced teams, sometimes in ICUs.
Although most cases of acute pancreatitis are uncomplicated and resolve spontaneously, the presence of
complications has significant prognostic importance. Necrosis, hemorrhage, and infection convey rates of up to
25%, 50%, and 80% mortality, respectively. Other complications such as pseudocyst formation,
pseudoaneurysm formation, or venous thrombosis increase morbidity and mortality to a lesser degree. The
presence of pancreatic infection must be avoided.
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